The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Naprosyn EC 250mg Gastro-resistant Tablets



Atnahs Pharma Netherlands B.V.PA22657/002/001

Main Information

Trade NameNaprosyn EC 250mg Gastro-resistant Tablets
Active SubstancesNaproxen
Dosage FormGastro-resistant tablet
Licence HolderAtnahs Pharma Netherlands B.V.
Licence NumberPA22657/002/001

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE02 naproxen

Status

License statusAuthorised
Licence Issued04/07/1990
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back